|
Volumn 281, Issue 5377, 1998, Pages 657-658
|
Genetic medicine - When will it come to the drugstore?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
ANTISENSE OLIGONUCLEOTIDE;
COMPLEMENTARY DNA;
DNA;
DOUBLE STRANDED DNA;
NUCLEIC ACID;
PEPTIDE NUCLEIC ACID;
POLYAMIDE;
RNA;
SINGLE STRANDED DNA;
CANCER THERAPY;
DRUG MARKETING;
GENE TARGETING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PRIORITY JOURNAL;
SHORT SURVEY;
CLINICAL TRIALS;
DNA;
GENE EXPRESSION REGULATION;
GENE TARGETING;
HUMANS;
NUCLEIC ACID CONFORMATION;
NYLONS;
OLIGONUCLEOTIDES, ANTISENSE;
PEPTIDES;
THIONUCLEOTIDES;
|
EID: 0032584571
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (17)
|
References (1)
|